Comparison of the exoS gene and protein expression in soil and clinical isolates of Pseudomonas aeruginosa

被引:40
作者
Ferguson, MW
Maxwell, JA
Vincent, TS
da Silva, J
Olson, JC
机构
[1] Coastal Carolina Univ, Dept Biol, Conway, SC 29528 USA
[2] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA
[3] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA
关键词
D O I
10.1128/IAI.69.4.2198-2210.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Exoenzyme S (ExoS) is translocated into eukaryotic cells by the type In: secretory process and has been hypothesized to function in conjunction with other virulence factors in the pathogenesis of Pseudomonas aeruginosa. To gain further understanding of how ExoS might contribute to P. aeruginosa survival and virulence, ExoS expression and the structural gene sequence were determined in P. aeruginosa soil isolates and compared with ExoS of clinical isolates. Significantly higher levels of ExoS ADP-ribosyltransferase (ADPRT) activity were detected in culture supernatants of soil isolates compared to those of clinical isolates. The higher levels of ADPRT activity of soil isolates reflected both the increased production of ExoS and the production of ExoS having a higher specific activity. ExoS structural gene sequence comparisons found the gene to be highly conserved among soil and clinical isolates with the greatest number of nonsynonymous substitutions occurring within the region of ExoS encoding GAP function. The lack of amino acid changes in the ADPRT region in association with a higher specific activity implies that other factors produced by P. aeruginosa or residues outside the ADPRT region are affecting ExoS ADPRT activity. The data are consistent with ExoS being integral to P. aeruginosa survival in the soil and suggest that, in the transition of P. aeruginosa from the soil to certain clinical settings, the loss of ExoS expression is favored.
引用
收藏
页码:2198 / 2210
页数:13
相关论文
共 63 条
  • [1] PRODUCTION OF EXOENZYME-S DURING PSEUDOMONAS-AERUGINOSA INFECTIONS OF BURNED MICE
    BJORN, MJ
    PAVLOVSKIS, OR
    THOMPSON, MR
    IGLEWSKI, BH
    [J]. INFECTION AND IMMUNITY, 1979, 24 (03) : 837 - 842
  • [2] BODEY GP, 1993, REV INFECT DIS, V5, P270
  • [3] Botzenhart K., 1993, Pseudomonas aeruginosa as an Opportunistic Pathogen, P1, DOI 10.1007/978-1-4615-3036-7_1
  • [4] USE OF AN IMPROVED CETRIMIDE AGAR MEDIUM AND OTHER CULTURE METHODS FOR PSEUDOMONAS AERUGINOSA
    BROWN, VI
    LOWBURY, EJL
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1965, 18 (06) : 752 - +
  • [5] CASH HA, 1979, AM REV RESPIR DIS, V119, P453
  • [6] COBURN J, 1991, J BIOL CHEM, V266, P6438
  • [7] Macrophages and epithelial cells respond differently to the Pseudomonas aeruginosa type III secretion system
    Coburn, J
    Frank, DW
    [J]. INFECTION AND IMMUNITY, 1999, 67 (06) : 3151 - 3154
  • [8] ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells
    Cowell, BA
    Chen, DY
    Frank, DW
    Vallis, AJ
    Fleiszig, SMJ
    [J]. INFECTION AND IMMUNITY, 2000, 68 (01) : 403 - 406
  • [9] Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils
    Dacheux, D
    Toussaint, B
    Richard, M
    Brochier, G
    Croize, J
    Attree, I
    [J]. INFECTION AND IMMUNITY, 2000, 68 (05) : 2916 - 2924
  • [10] ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
    FinckBarbancon, V
    Goranson, J
    Zhu, L
    Sawa, T
    WienerKronish, JP
    Fleiszig, SMJ
    Wu, C
    MendeMueller, L
    Frank, DW
    [J]. MOLECULAR MICROBIOLOGY, 1997, 25 (03) : 547 - 557